Table 2.
Cardiac Structural Measures | LV Function Measures | |||||||
---|---|---|---|---|---|---|---|---|
Log‐LVMI | LAD | FS | Log‐E/e′ | |||||
Estimate | P Value | Estimate | P Value | Estimate | P Value | Estimate | P Value | |
Leptin | −0.037 | <0.0001a | −0.039 | <0.0001a | 0.009 | 0.92 | 0.009 | 0.14 |
LR | 0.009 | 0.002a | 0.008 | 0.21 | −0.107 | 0.08 | −0.016 | 0.0002a |
FLI | −0.024 | <0.0001a | −0.028 | 0.001a | 0.050 | 0.52 | 0.014 | 0.0055 |
FABP4 | −0.019 | <0.0001a | −0.010 | 0.18 | 0.047 | 0.52 | 0.002 | 0.61 |
RBP4 | 0.012 | <0.0001a | 0.025 | 0.0001a | −0.068 | 0.29 | −0.007 | 0.09 |
Fetuin‐A | −0.002 | 0.45 | −0.006 | 0.24 | 0.11 | 0.04 | 0.005 | 0.13 |
Adiponectin | −0.002 | 0.57 | 0.008 | 0.20 | −0.061 | 0.34 | 0.004 | 0.26 |
Estimates are β coefficients per 1‐SD increase for each within‐sex standardized adipokine. Models are adjusted for cohort, age, sex, height, weight, systolic blood pressure, diastolic blood pressure, heart rate, diabetes mellitus, antihypertensive treatment, smoking, serum creatinine, high‐density lipoprotein, low‐density lipoprotein, and triglycerides. FABP4 indicates fatty acid–binding protein 4; FLI, free leptin index; FS, fractional shortening; LAD, left atrial diameter in end systole; LR, leptin receptor; LV, left ventricular; LVMI, LV mass index; RBP4, retinol‐binding protein 4.
Bonferroni‐corrected P≤0.002.